Avance Biosciences is excited to exhibit at the ASGCT 2025 conference in New Orleans, LA, from May 13–17, 2025. Join us to explore our expert bioanalytical solutions for gene and cell therapy development. Visit booth #750 to learn how we can support your therapeutic advancements...
Avance Biosciences™ is joining the 2025 AAPS National Biotechnology Conference to showcase our expertise in biological assay development, validation, and sample testing. Visit our booth to learn more about our innovative solutions and explore potential collaborations in drug development...
Avance Biosciences is excited to participate in the World Vaccine Congress 2025, showcasing our advanced solutions in vaccine development, bioanalytics, and regulatory compliance. Join us to explore collaboration opportunities and learn how our services can support your vaccine research and clinical trials...
Avance Biosciences is excited to join WRIB 2025 in New Orleans, showcasing our expertise in bioanalytical testing for biologics and biosimilars. Visit us at Booth #78 to explore our advanced solutions, including LBA, Flow Cytometry, qPCR, and LC-MS/MS. [...]
Avance Biosciences contributed critical RNA sequencing to the development of MV-014-212, a novel intranasal COVID-19 vaccine. In preclinical trials, MV-014-212 showed significant promise by reducing viral shedding and eliciting a broad immune response, including protection against multiple variants of concern...
Avance Biosciences offers CLIA-compliant testing services to ensure accurate, reliable data throughout drug development. From biomarker validation to regulatory support, our expertise helps biopharmaceutical companies advance clinical trials and bring innovative biologic treatments to market with confidence...
HOUSTON, Feb. 26, 2025 /PRNewswire/ -- Avance Biosciences, a leading provider of high-quality analytical and bioanalytical services for the pharmaceutical industry, is pleased to announce that it has successfully registered with the Clinical Laboratory Improvement Amendments (CLIA) program. This registration allows Avance Biosciences to operate under its assigned CLIA number and offer high-complexity laboratory testing [...]
Well, well, well... it was a TREAT — and a big one for a lucky few! Avance fully embraced Halloween last Thursday with a costume contest, candy galore, and a pizza party. The costume contest was a great way to bring everyone together, with employees voting for winners in five fun categories [...]
Avance Biosciences is excited to announce its participation in the upcoming SITC Conference, taking place from November 6-10, 2024, in Houston TX. This premier event is focused on improving outcomes for cancer patients by incorporating strategies based on basic and applied cancer immunotherapy. [...]
Avance Biosciences™ offers top-tier GLP & GMP compliant services in assay development, validation, & sample testing for biopharma. Visit our booth to explore how we support drug discovery, development, & manufacturing with precision & expertise. [...]
Avance Biosciences is a leading Contract Research Organization (CRO) and Contract Testing Organization (CTO) providing CGMP and GLP-compliant analytical and bioanalytical services to support drug development. From early discovery through clinical development and commercialization, we provide CGMP and GLP-compliant services tailored to your therapeutic modality and regulatory needs.
